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Statin lipid-lowering drugs have been shown to induce muscular stress conditions and 
increase incidence of myopathy, especially in exercising individuals. RhoA, a GTPase 
involved in muscle repair and intracellular damage signaling, adapts both acutely 
(increased activation) and chronically (increased protein expression) to muscular stress 
conditions. Statins inhibit production of mevalonate, upstream of geranylgeranyl 
pyrophosphate (GGPP), which anchors newly translated RhoA to the cell membrane. 
This inhibition may suppress the ability to chronically increase RhoA expression.  
Purpose: To determine if exercise and statin treatment elicit different RhoA adaptations 
to muscular stress conditions.  Methods: Mice were randomized into vehicle (Veh) 
control, one of three simvastatin doses (60, 200, or 400 mg · kg-1), or Veh plus intense 
eccentric exercise (Veh+EX). After two weeks, tibialis anterior muscle was harvested and 
analyzed via western blot for RhoA activity (percentage activated) and total RhoA 
expression.  Results: Both the Veh+EX and all statin groups had elevated RhoA activity 
(p<0.05). RhoA expression increased in the Veh+EX group (p<0.01), but was unchanged 
between Veh and statin groups. There were no significant differences between statin 
doses.  Conclusion: The increased RhoA activity with statin treatment and exercise 
shows a similar acute adaptation to stress, but the expected increase in RhoA expression 
was suppressed by all doses of simvastatin. This may play a role in the increased 
myopathy rate observed in exercising statin users. Future study should investigate if other 
signaling proteins modified by GGPP are also affected. 
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 Control 
(Veh) 
Exercise 
(Veh+EX) 
Statin 60  
 mg · kg-1 
Statin 200  
mg · kg-1 
Statin 400   
mg · kg-1 
RhoA 
Expression (AU) 
527 ± 12 801 ± 22* 470 ± 73 541 ± 15 497 ± 22 
RhoA Activity 
(%) 
14.7 ± 1.1 20.0 ± 1.2* 22.9 + 1.7* 19.5 ± 1.6* 18.5 ± 1.5* 
